Matching risk with treatment strategies in deep vein thrombosis management

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 6 SUPPL. 2, 1999, Pages

  Arcelus, J I ^a,d   Caprini, J A ^b,c   Motykie, G D ^b,c   Reyna, J J ^a  

^a Especialidad en Oftalmología Hospital Comarcal de la Axarquía Vélez Málaga Málaga   (Spain)

^b Evanston Northwestern Healthcare ^*  (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Hospital de l'Axarquía   (Spain)

Author keywords

Prevention; Risk assessment models; Risk factors; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ESTROGEN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

BLEEDING; COMPRESSION THERAPY; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; HUMAN; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; TREATMENT PLANNING;

DISEASE MANAGEMENT; FEMALE; HUMANS; PREMEDICATION; RISK ASSESSMENT; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0032850440     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. National Institutes of Health Consensus Conference on prevention of venous thrombosis and pulmonary embolism. JAMA 1986; 256: 744-748.
2. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of prophylaxis for venous thromboembolism in hospital patients. BMJ 1992; 305: 567-574.
3. Nicolaides AN, Arcelus JI, Belcaro G, Bergqvist D, Borris LC, Buller HR. et al. Prevention of venous thromboembolism. Int Angiol 1992; 11: 151-159.
4. Clagett GP, Anderson FA, Heit J, Lavine MN, Wheeler HB. Prevention of venous thromboembolism. Chest 1995; 108: 312S-334S.
5. Nicolaides AN, Bergqvist D, Hull R, Ackchurin RS, Allegra C, Arcelus J, et al. Consensus statement: prevention of venous thromboembolism. Int Angiol 1997; 16: 3-38.
6. Conti S, Daschbach M. Venous thromboembolism prophylaxis: a survey of its use in the United States. Arch Surg 1982; 74: 205-210
7. Fletcher JP, Koutts J, Ockelford PA. Deep vein thrombosis prophylaxis: a survey of current practice in Australia and New Zealand. Aust N Z J Surg 1992; 62: 601-605.
8. Caprini JA, Arcelus JI, Hoffman K, Mattern T, Laubach M, Size GP, et al. Prevention of venous thromboembolism in North America: results of a survey among general surgeons. J Vasc Surg 1994; 20: 751-758.
9. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med 1991; 115: 591-595.
10. Keane MG, Ingenito EP, Goldhaber SZG. Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest 1994; 106: 13-14.
11. Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 1991; 17 (suppl 3):304-312.
12. Morris GK. Prevention of venous thromboembolism: a survey of methods used by orthopaedic and general surgeons. Lancet 1980; ii: 572-574.
13. Bergqvist D. Prophylaxis against postoperative venous thromboembolism: a survey of surveys. Thromb Haemorrh Disorders 1990; 2: 69-73.
14. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Ann Surg 1988; 208: 227-240.
15. Wells PS, Lensing AW, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism: a meta-analysis. Arch Intern Med 1994; 154: 67-72.
16. Caprini JA, Traverso CI, Arcelus JI. Intermittent pneumatic compression. In: Bergqvist D et al. (editors). Prevention of Venous Thromboembolism. London: Med-Orion Publishing, 1994; 209-224.
17. Ramos R, Salem BI, De Pawlikowski P, Coordes C, Eisenberg S, Leidenfrost R. The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest 1996; 109: 82-85.
18. Comerota AJ, Katz ML, White JV. Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? Am J Surg 1992; 164: 265-268.
19. Stokes EE, White DB, Caprini JA, et al. Implementation of compression modalities in the prevention of postoperative deep vein thrombosis. Dermatol Surg 1995; 21: 95 (Abstract).
20. Gillies TE, Ruckley CV, Nixon SJ. Still missing the boat with fatal pulmonary embolism. Br J Surg 1996; 83: 1394-1395.
21. Storti S, Crucitti P, Cina G. Risk factors and prevention of venous thromboembolism. RAYS 1996; 21: 439-460.
22. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Changing clinical practice: prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med 1994; 154: 669-677.
23. Avery CME, Jamieson N, Calne RY. Effective administration of heparin and antibiotic prophylaxis. Br J Surg 1995; 82: 1136-1137.
24. Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305: 913-920.
25. Nurmohamed MT, Rosendaal, Büller HR, Dekker E, Hommes DW, Vandenbroucke JP, Briet E. Low-molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340: 152-156.
26. Jørgensen LN, Wille-Jørgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993; 80: 689-704.
27. Imperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994; 271: 1780-1785.
28. Bounameaux H, Huber O, Khabiri E, Schneider PA, Didier D, Rohner A. Unexpectedly high rate of phlebographic deep venous thrombosis following elective general abdominal surgery among patients given prophylaxis with low-molecular-weight heparin. Arch Surg 1993; 128: 326-328.
29. Hull RC, Raskob GE, Pineo GF, Rosenbloom D, Evans W, Mallory T, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329: 1370-1376.
30. RD Heparin Arthroplasty Group. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg 1994; 76A: 1174-1185.
31. Leclerc JR, Geerts WH, Desjardins L, Laflamme GH, L'Esperance B, Demers C, et al. Prevention of venous thromboembolism after knee arthroplasty: a randomized, double-blind trial, comparing a low molecular weight heparin treatment (enoxaparin) to warfarin. Ann Intern Med 1996; 124: 619-626.
32. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J Royal Soc Med 1989; 82: 203-206.
33. Kakkar VV, Howe C, Nicolaides AN, Renney JT, Clarke MB. Deep vein thrombosis of the leg: is there a high risk group? Am J Surg 1970; 20: 527-530.
34. Nicolaides AN, Irving D. Clinical factors and the risk of deep venous thrombosis. In: Nicolaides AN (editor). Thromboembolism: Aetiology, Advances in Prevention and Treatment. Lancaster: MTP, 1975; 193-204.
35. Clayton JK, Anderson JA, McNicol GP. Pre-operative prediction of postoperative deep vein thrombosis. BMJ 1976; 16: 910-912.
36. Crandon AJ, Peel KR, Anderson JA, Thompson V, McNicol GP. Postoperative deep vein thrombosis: identifying high-risk patients. BMJ 1980; 7: 343-344.
37. Rackozi J, Chamone D, Verstraete M, Collen D. The relevance of clinical and hemostasis parameters for the prediction of postoperative thrombosis of the deep veins of the lower extremity in gynecologic patients. Surg Gynecol Obstet 1980; 151: 225-231.
38. Lowė GDO, Osborne DM, McArdle BM, Smith A, Carter DC, Forbes CD. Prediction and selective prophylaxis of venous thrombosis in elective gastro-intestinal surgery. Lancet 1982; i: 409-412.
39. Kjaergaard J, Esbesen K, Wille-Jørgensen P, Jørgensen T, Thorup J, Berning H, Wold S. A multivanate pattern recognition study of risk factors indicating postoperative thromboembolism despite low-dose heparin in major abdominal surgery. Thromb Haemost 1985; 54: 409-412.
40. Sue-Ling HM, Johnston D, McMahon MJ, Philips PR, Davies JA. Pre-operative identification of patients at high risk of deep venous thrombosis after elective major abdominal surgery. Lancet: 1986; i: 1173-1176.
41. Janssen HF, Schachner J, Hubbard J, Hartman JT. The risk of deep venous thrombosis: a computerized epidemiologic approach. Surgery 1987; 101: 205-212.
42. Clarke-Pearson D, Delong ER, Synan IS, Coleman RE, Creasman WT. Variables associated wich postoperative deep venous thrombosis. Obstet Gynecol. 1987; 69: 146-150.
43. Rocha E, Alfaro JA, Páramo JM, Canadell JM. Preoperative identification of patients at high risk of deep venous thrombosis despite prophylaxis in total hip replacement. Thromb Haemost 1988; 59: 93-95.
44. Wille-Jørgensen P, Ott P. Predicting failure of low-dose prophylactic heparin in general surgical procedures. Surg Gynecol Obstet 1990; 171: 126-130.
45. Arcelus JI, Candocia S, Traverso CI, Fabrega F, Caprini JA, Hasty JH. Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost 1991; 17 (suppl 3): 313-318.
46. Traverso Cl, Arcelus JI, Gómez E, et al. Prospective assessment of the risk of deep vein thrombosis in elective abdominal surgery. Predictive role of thrombelastography. Thromb Hamorrh Disorders 1993; 7: 9-15.
47. Brandjes DP, ten Cate JW, Büller HR. Pre-surgical identification of the patient at risk for developing venous thromboembolism post-operatively. Acta Chir Scand 1990; suppl 556: 18-21.
48. Comité Scientifique Thrombose de l'APHP. Prophylaxie de thromboses veineuses postopératoires: recommandations de l'Assistance publique-Hôpitaux de Paris. Sang Thromb Vaiss 1995; 7: 119-120.
49. Haas S. Risikoabschätzung thromboembolischer Komplikationen bei chirurgischen Erkrankungen und Verletzungen. Aktuel Chir 1996; 31: 269-275.